Comprehensive Pan-Cancer Analysis of the Prognostic and Immunological Roles of the METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C Axis
暂无分享,去创建一个
Juan Wang | L. Tang | Yixiao Yuan | Lincan Duan | Xiulin Jiang | X. Zou | Qianqian Liu
[1] Yong Duan,et al. miR-133b targets NCAPH to promote β-catenin degradation and reduce cancer stem cell maintenance in non-small cell lung cancer , 2021, Signal Transduction and Targeted Therapy.
[2] M. Zou,et al. miR-17-5p accelerates cervical cancer cells migration and invasion via the TIMP2/MMPs signaling cascade , 2021, Cytotechnology.
[3] W. Jin,et al. MiR-513b-5p represses autophagy during the malignant progression of hepatocellular carcinoma by targeting PIK3R3 , 2021, Aging.
[4] A. Addeo,et al. TMB or not TMB as a biomarker: That is the question. , 2021, Critical reviews in oncology/hematology.
[5] Jie Liu,et al. Silencing of hsa_circ_0009035 Suppresses Cervical Cancer Progression and Enhances Radiosensitivity through MicroRNA 889-3p-Dependent Regulation of HOXB7 , 2021, Molecular and Cellular Biology.
[6] Xiaohong Wang,et al. m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis , 2021, Journal of Hematology & Oncology.
[7] A. Chiang,et al. UBE2C Drives Human Cervical Cancer Progression and Is Positively Modulated by mTOR , 2020, Biomolecules.
[8] J. Huse,et al. YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis. , 2020, Cancer cell.
[9] L. Ger,et al. UBE2C is a Potential Biomarker for Tumorigenesis and Prognosis in Tongue Squamous Cell Carcinoma , 2020, Diagnostics.
[10] Yangqiu Li,et al. Roles of METTL3 in cancer: mechanisms and therapeutic targeting , 2020, Journal of Hematology & Oncology.
[11] Zhon-Yin Zhang,et al. Long non‐coding RNA SCARNA2 induces cutaneous squamous cell carcinoma progression via modulating miR‐342‐3p expression , 2020, The journal of gene medicine.
[12] Chang Hoon Shin,et al. MicroRNA-17-5p regulates EMT by targeting vimentin in colorectal cancer , 2020, British Journal of Cancer.
[13] T. Kouzarides,et al. Role of RNA modifications in cancer , 2020, Nature Reviews Cancer.
[14] Ningning Yang,et al. lncRNA SNHG11 promotes lung cancer cell proliferation and migration via activation of Wnt/β‐catenin signaling pathway , 2020, Journal of cellular physiology.
[15] Yanhua Kang,et al. Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis. , 2020, Cancer biotherapy & radiopharmaceuticals.
[16] P. Wei,et al. MiR-140-3p Ameliorates the Progression of Osteoarthritis via Targeting CXCR4. , 2020, Biological & pharmaceutical bulletin.
[17] X. Gou,et al. Long noncoding RNA TUG1 regulates prostate cancer cell proliferation, invasion and migration via the Nrf2 signaling axis. , 2020, Pathology, research and practice.
[18] Xuehao Wang,et al. M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma , 2020, Journal of Hematology & Oncology.
[19] Haiyan Ye,et al. Up-regulation of circ_LARP4 suppresses cell proliferation and migration in ovarian cancer by regulating miR-513b-5p/LARP4 axis , 2020, Cancer Cell International.
[20] Xiuling Zhi,et al. Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1. , 2019, Biochemical and biophysical research communications.
[21] Shen Hu,et al. UBE2C promotes the progression of head and neck squamous cell carcinoma. , 2019, Biochemical and biophysical research communications.
[22] Xiaomei Li,et al. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non‐small cell lung cancer cells via the miR‐361‐3p/FRAT1 axis , 2019, Thoracic cancer.
[23] Jia Liu,et al. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer , 2019, Molecular Cancer.
[24] Li-xiu Liu,et al. MiR-525-5p Repressed Metastasis and Anoikis Resistance in Cervical Cancer via Blocking UBE2C/ZEB1/2 Signal Axis , 2019, Digestive Diseases and Sciences.
[25] Hongbo Wang,et al. UBE2C Is Upregulated by Estrogen and Promotes Epithelial–Mesenchymal Transition via p53 in Endometrial Cancer , 2019, Molecular Cancer Research.
[26] Q. Ding,et al. Anticancer effect of icaritin on prostate cancer via regulating miR‐381‐3p and its target gene UBE2C , 2019, Cancer medicine.
[27] Beibei Ru,et al. TISIDB: an integrated repository portal for tumor-immune system interactions , 2019, Bioinform..
[28] Wei Wu,et al. Combined elevation of AURKB and UBE2C predicts severe outcomes and therapy resistance in glioma. , 2019, Pathology, research and practice.
[29] F. Shao,et al. Long non-coding RNA TUG1-mediated down-regulation of KLF4 contributes to metastasis and the epithelial-to-mesenchymal transition of colorectal cancer by miR-153-1 , 2019, Cancer management and research.
[30] Kaiyu Qian,et al. Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma , 2019, Aging.
[31] D. Lin,et al. METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma , 2019, Molecular Cancer.
[32] Mengquan Li,et al. SNHG1 contributes to proliferation and invasion by regulating miR-382 in breast cancer , 2019, Cancer management and research.
[33] T. Li,et al. LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis. , 2019, European review for medical and pharmacological sciences.
[34] Jun Zhao,et al. UBE2C overexpression in melanoma and its essential role in G2/M transition , 2019, Journal of Cancer.
[35] Joshua M. Korn,et al. Next-generation characterization of the Cancer Cell Line Encyclopedia , 2019, Nature.
[36] H. Shan,et al. m6A-induced lncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1 , 2019, Molecular Cancer.
[37] Y. Xiong,et al. UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells , 2019, Bioscience reports.
[38] Xiaohong Wang,et al. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC , 2019, Theranostics.
[39] N. Brockdorff,et al. m6A modification of non-coding RNA and the control of mammalian gene expression. , 2019, Biochimica et biophysica acta. Gene regulatory mechanisms.
[40] Aiying Zhang,et al. Identification of key genes and pathways in hepatocellular carcinoma , 2019, Medicine.
[41] A. Jemal,et al. Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.
[42] O. Rando,et al. Transgenerational Epigenetic Inheritance. , 2018, Annual review of genetics.
[43] Min Liu,et al. The lncRNA SCARNA2 mediates colorectal cancer chemoresistance through a conserved microRNA‐342‐3p target sequence , 2018, Journal of cellular physiology.
[44] Wei Liu,et al. CancerSEA: a cancer single-cell state atlas , 2018, Nucleic Acids Res..
[45] Yu-qin Pan,et al. The long noncoding RNA SNHG1 regulates colorectal cancer cell growth through interactions with EZH2 and miR-154-5p , 2018, Molecular Cancer.
[46] Yan Chen,et al. LncRNA TUG1 promotes cells proliferation and inhibits cells apoptosis through regulating AURKA in epithelial ovarian cancer cells , 2018, Medicine.
[47] J. Borst,et al. CD4+ T cell help in cancer immunology and immunotherapy , 2018, Nature Reviews Immunology.
[48] Zhen Cao,et al. The lncLocator: a subcellular localization predictor for long non‐coding RNAs based on a stacked ensemble classifier , 2018, Bioinform..
[49] T. Schumacher,et al. Regulation and Function of the PD-L1 Checkpoint. , 2018, Immunity.
[50] G. Ma,et al. Overexpression of UBE2C correlates with poor prognosis in gastric cancer patients. , 2018, European review for medical and pharmacological sciences.
[51] Yanyan Li,et al. Long noncoding RNA SNHG1 promotes non‐small cell lung cancer progression by up‐regulating MTDH via sponging miR‐145–5p , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[52] Zuozhang Yang,et al. GRK5 functions as an oncogenic factor in non-small-cell lung cancer , 2018, Cell Death & Disease.
[53] Yuan-yuan Liu,et al. LncRNA SNHG1 enhances cell proliferation, migration, and invasion in cervical cancer. , 2018, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[54] Jing Wang,et al. LinkedOmics: analyzing multi-omics data within and across 32 cancer types , 2017, Nucleic Acids Res..
[55] Jun S. Liu,et al. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. , 2017, Cancer research.
[56] E. Sherwood,et al. Targeting Immune Cell Checkpoints during Sepsis , 2017, International journal of molecular sciences.
[57] F. Kühnel,et al. CD4 and CD8 T lymphocyte interplay in controlling tumor growth , 2017, Cellular and Molecular Life Sciences.
[58] Gui-Shuan Wang,et al. Hsa-miR-513b-5p suppresses cell proliferation and promotes P53 expression by targeting IRF2 in testicular embryonal carcinoma cells. , 2017, Gene.
[59] W. Jiang,et al. Therapeutic Role of MiR-140-5p for the Treatment of Non-small Cell Lung Cancer. , 2017, Anticancer research.
[60] Chad J. Creighton,et al. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses , 2017, Neoplasia.
[61] Yan Gao,et al. LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145 , 2017, Acta biochimica et biophysica Sinica.
[62] Ge Gao,et al. CPC2: a fast and accurate coding potential calculator based on sequence intrinsic features , 2017, Nucleic Acids Res..
[63] Cheng Li,et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..
[64] Zhike Lu,et al. m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. , 2017, Cancer cell.
[65] S. Wen,et al. Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan–Meier plotter , 2017, PloS one.
[66] A. Butte,et al. xCell: digitally portraying the tissue cellular heterogeneity landscape , 2017, Genome Biology.
[67] 賢治 高橋,et al. 膵癌とlong non-coding RNA , 2016 .
[68] Yan Fu,et al. MicroRNA-17-5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signaling , 2015, Journal of Biological Research-Thessaloniki.
[69] Jun Ma,et al. Ubiquitin-conjugating enzyme E2C regulates apoptosis-dependent tumor progression of non-small cell lung cancer via ERK pathway , 2015, Medical Oncology.
[70] Hui Zhou,et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..
[71] Joshua C. Gilbert,et al. An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules , 2013, Cell.
[72] A. Jouvet,et al. Molecular characterization of central neurocytomas: Potential markers for tumor typing and progression , 2013, Neuropathology : official journal of the Japanese Society of Neuropathology.
[73] Qun Chen,et al. Prognostic significance of serum miR-17-5p in lung cancer , 2013, Medical Oncology.
[74] Sridhar Ramaswamy,et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..
[75] Hui Zhang,et al. Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker , 2012, Tumor Biology.
[76] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[77] T. Strutt,et al. Expanding roles for CD4+ T cells in immunity to viruses , 2012, Nature Reviews Immunology.
[78] M. Otsuka,et al. MicroRNA-22 and microRNA-140 suppress NF-κB activity by regulating the expression of NF-κB coactivators. , 2011, Biochemical and biophysical research communications.
[79] S. Roychoudhury,et al. Spindle Assembly Checkpoint Protein Cdc20 Transcriptionally Activates Expression of Ubiquitin Carrier Protein UbcH10* , 2011, The Journal of Biological Chemistry.
[80] Thangarajan Rajkumar,et al. Identification and validation of genes involved in cervical tumourigenesis , 2011, BMC Cancer.
[81] L. Sherman,et al. CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes. , 2010, Cancer research.
[82] Per Karlsson,et al. Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma , 2010, Clinical Cancer Research.
[83] C. Boland,et al. Microsatellite instability in colorectal cancer. , 2010, Gastroenterology.
[84] Xian-xi Liu,et al. Association of clinicopathological features with UbcH10 expression in colorectal cancer , 2010, Journal of Cancer Research and Clinical Oncology.
[85] J. V. van Deursen,et al. Overexpression of the E2 ubiquitin–conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation , 2010, The Journal of cell biology.
[86] R. Lotan,et al. Identification of Gene Signatures and Molecular Markers for Human Lung Cancer Prognosis using an In vitro Lung Carcinogenesis System , 2009, Cancer Prevention Research.
[87] K. Nakai,et al. PrognoScan: a new database for meta-analysis of the prognostic value of genes , 2009, BMC Medical Genomics.
[88] A. Fusco,et al. Analysis of UbcH10 expression represents a useful tool for the diagnosis and therapy of astrocytic tumors. , 2008, Clinical neuropathology.
[89] K. Mimori,et al. Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin‐conjugating enzyme E2C gene expression , 2007, International journal of cancer.
[90] Viji M. Draviam,et al. Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities , 2007, Nature.
[91] M. Guida,et al. UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas , 2007, Oncogene.
[92] D. Beer,et al. Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma. , 2006, Neoplasia.
[93] Marc W. Kirschner,et al. The Processivity of Multiubiquitination by the APC Determines the Order of Substrate Degradation , 2006, Cell.
[94] Akira Nakagawara,et al. UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme. , 2003, Cancer research.
[95] A. Admon,et al. E2-C, a cyclin-selective ubiquitin carrier protein required for the destruction of mitotic cyclins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[96] J. Yuan,et al. LncRNA TUC338 promotes invasion of lung cancer by activating MAPK pathway. , 2018, European review for medical and pharmacological sciences.